The future of weight loss is fast approaching. At a recent scientific conference, drug companies showed off a variety of next-generation drugs for both obesity and type 2 diabetes. Some of these treatments might help people lose even more weight than current forerunners like Novo Nordisk’s semaglutide—the active…
As Novo Nordisk and Eli Lilly struggle to keep up with soaring demand for their popular diabetes and weight loss drugs, healthcare companies are introducing supply trackers to help patients navigate ongoing shortages.
The millennial-skewed telehealth platform Hims & Hers announced Monday that is now offering customers a compounded version of semaglutide, the active ingredient in popular weight loss drugs like Ozempic and Wegovy.
Senator Bernie Sanders (I-VT) is taking aim at one of Big Pharma’s newest cash cows: the latest generation of effective obesity medications.
In our top science stories this week, reporter Ed Cara explores the similarities and differences between today’s popular obesity drugs and fen-phen, a briefly trendy weight loss aid that was pulled from the market after doctors discovered dangerous side effects. NASA confirmed that a chunk of debris that crashed into…
The newest weight loss drug on the market, Zepbound, might also help keep people’s snoring down.
The drug Ozempic, after just a few years on the market, has already become a household name synonymous with weight loss.
Pharmaceutical company Eli Lilly is making a plea to some of its customers: stop hoarding our weight loss drugs. In a new Oscar-themed commercial set to run on TV this weekend, the drugmaker is not-so-subtly telling people to stay away from its new blockbuster medications if they’re only looking to lose a few pounds.…
The 46-year-old Voyager 1 spacecraft is on the fritz again, and this time it may be critical. As one engineer said, “this is, by far, the most serious since I’ve been project manager.” Here are our top science stories from this week.
The newest obesity drug on the market, Eli Lilly’s tirzepatide, may also help keep people’s blood pressure in check, new research out Monday has shown. The study looked at clinical trial participants and found that people taking it experienced a drop in their systolic blood pressure on average compared to a placebo…
